Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, UK; Department of Radiotherapy, Policlinico Umberto I, "Sapienza" University of Rome, Rome, Italy.
Department of Clinical Oncology, Guy's and St Thomas' NHS Trust, London, UK.
Oral Oncol. 2021 Aug;119:105365. doi: 10.1016/j.oraloncology.2021.105365. Epub 2021 May 29.
Head and neck squamous cell carcinoma (HNSCC) has a significant impact on patients' quality of life and treatment can be associated with severe morbidity. Following completion of treatment, patients are followed up in order to detect potentially salvageable recurrences and to manage long-term toxicities. In recent years, a growing interest has been given to risk stratified follow-up interventions to prevent and detect recurrences and manage treatment toxicities in other tumour sites as well as to transfer some of that care to community services. We review the literature for HNSCC and propose a risk stratified follow up protocol to address these issues and assist clinicians in decision making. A shift in patterns of care is suggested in order to provide a basis to improve care for HNSCC patients after complete response to primary treatment.
头颈部鳞状细胞癌 (HNSCC) 对患者的生活质量有重大影响,治疗可能会导致严重的发病率。治疗完成后,对患者进行随访,以检测可能挽救的复发,并管理长期毒性。近年来,人们越来越关注风险分层的随访干预措施,以预防和检测复发,并管理其他肿瘤部位的治疗毒性,以及将部分护理转移到社区服务。我们回顾了 HNSCC 的文献,并提出了风险分层随访方案来解决这些问题,并帮助临床医生做出决策。建议改变护理模式,为原发性治疗完全缓解后的 HNSCC 患者提供改善护理的基础。